Featured Stories

Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.

Yash Dilipbhai Dharsandia

Imagine being a young man, just 27, on the cusp of building your career and family life, when a r…




Junagadh, Gujarat

Sudhanshu Agrawal

My name is Sudhanshu Agrawal, and I’m an operations manager at Policybazaar. I live in Delh…

Pankaj Giri

People who have faced pancreatitis have their own experiences, but the common thread in their sto…

Sonali Dixit

My name is Sonali Dixit, and I want to share my long and arduous journey with pancreatitis. It&rs…




Noida, Uttar Pradesh

Rajni Mathur

My name is Rajni Mathur, and I’m a 55-year-old teacher in a government school in Delhi. For…




Noida, Uttar Pradesh

Robin Singh

This story narrates the journey of Robin Singh, a healthy, 30-year-old businessman and gym-goer, …




Kurukshetra, Haryana

All Stories

Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.

Shalini Garg

Shalini Garg

IBS (Irritable Bowel Syndrome)




Delhi

This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…

Gaurav Kumar

Gaurav Kumar

Chronic Calcific Pancreatitis




Delhi

For over a decade, Gaurav Kumar was trapped in a relentless cycle of agony and hospitalization, b…

Avichal Dixit

Avichal Dixit

Chronic Calcific Pancreatitis




Pilibhit, Uttar Pradesh

This narrative traces the rapid systemic degradation faced by Avichal Dixit, a talented young stu…

Ravinder Kumar

Ravinder Kumar

Recurrent Acute Pancreatitis, Diabetes




Panipat, Haryana

This story is a powerful testament to resilience and hope. It narrates the journey of Ravinder Ku…

Rohit Gupta

Rohit Gupta

Chronic Pancreatitis




New Delhi

This is the story of Rohit Gupta , whose resilience transformed a seemingly insurmountable clinic…

Vivaan Guleria

Vivaan Guleria

Acute on Chronic Pancreatitis




Dharamshala, Himachal Pradesh

This story is a powerful testament to resilience and hope. It narrates the journey of Vivaan Gule…

Our Research

At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.

Remission in a Relapse Case of Acute Promyelocytic Leukaemia for Twenty-two years using Metal Based Ayurvedic Treatment: A Case Report

Remission in a Relapse Case of Acute Promyelocytic Leukaemia for Twenty-two years using Metal Based Ayurvedic Treatment: A Case Report

Acute Promyelocytic Leukemia (APML) is a blood cancer with symptoms like anemia, fatigue, and easy bleeding. While modern treatments improve outcomes, relapses and side effects persist. This case report discusses an APML patient who, after relapse, opted for Ayurvedic treatment with metal-based formulations, achieving remission within weeks. The patient has remained disease-free for 22 years.

Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District

Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District

This study evaluated the effect of Ayurvedic preparations Sootshekhar Rasa (SR) and Sitopaladi Churna (SC) with iron and folic acid (IFA) on nutritional anaemia in 820 adolescents in Dehradun, India. After 90 days of treatment, all groups showed increased haemoglobin levels, with the best results in the group receiving SR + SC + IFA. No major side effects were reported, and the treatment led to sustainable improvements in anaemia.

Randomized Controlled Study to Evaluate Prophylactic Properties of Ayurvedic Treatment Protocol in Refractory and Chronic Migraine Patients

Randomized Controlled Study to Evaluate Prophylactic Properties of Ayurvedic Treatment Protocol in Refractory and Chronic Migraine Patients

This study compared Ayurvedic treatment to conventional therapy for chronic refractory migraine. After 360 days, the Ayurvedic group showed greater reductions in headache days, VAS, and MIDAS scores (p

Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies

Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies

Prak-20, an ayurvedic herbo-mineral formulation, was studied for its hepato-protective effects in rats. It showed no significant liver damage or elevated enzyme levels compared to controls. In higher doses, it reduced liver enzymes by up to 54% and minimized liver damage. These results suggest Prak-20 is effective in protecting the liver, with further research needed on its mechanism.

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute promyelocytic leukemia (APML) is a subtype of leukemia marked by anemia, infections, and bleeding. It is diagnosed through bone marrow tests and the PML-RARα fusion gene. Recent treatments with ATRA and arsenic trioxide have improved survival rates, but challenges like side effects and relapses remain. A 1982 case of a patient who survived 37 years without standard treatment suggests potential alternative therapies.

Case studies on prophylactic ayurvedic therapy in migraine patients

Case studies on prophylactic ayurvedic therapy in migraine patients

Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.